Sinusitis tied to elevated rheumatic disease risk

The common inflammatory condition sinusitis is linked to a 40% heightened risk of a subsequent diagnosis of rheumatic disease, particularly in the 5 to 10 years preceding the start of symptoms, finds research published in the open access journal RMD Open.

MHRA greenlights donanemab for early stage Alzheimer’s disease

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 23 October 2024, approved a license for the medicine donanemab (Kisunla) for use in the

October 26, 2024

What’s indoor air quality like in long-term care facilities during wildfires? Worse than you’d think.

Every year, wildfires across the western U.S. and Canada send plumes of smoke into the sky. When that smoke blows into southwestern Idaho’s Treasure Valley,

January 23, 2024

Formycon publishes nine-month results for 2023 – Biotech Investments

EQS-News: Formycon AG / Key word(s): 9 Month figures/Quarterly / Interim Statement Formycon publishes nine-month results for 2023 13.11.2023 / 07:30 CET/CEST The issuer is

November 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.